dwc20155
Small moleculeexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT02704559)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dwc20155
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03184415 | Phase 3 | Jul 3, 2017 | Daewoong Pharmaceutical Co. LTD. |
| NCT03005223 | Phase 1 | Jan 4, 2017 | Daewoong Pharmaceutical Co. LTD. |
| NCT02952755 | Phase 1 | Nov 28, 2016 | Daewoong Pharmaceutical Co. LTD. |
| NCT02952547 | Phase 1 | Oct 30, 2016 | Daewoong Pharmaceutical Co. LTD. |
| NCT02947139 | Phase 1 | Sep 29, 2016 | Daewoong Pharmaceutical Co. LTD. |
| NCT03016494 | Phase 1 | Feb 1, 2016 | Daewoong Pharmaceutical Co. LTD. |
| NCT02704559 | Phase 1 | Dec 1, 2015 | Daewoong Pharmaceutical Co. LTD. |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daewoong Pharmaceutical Co. LTD. | For profit | 7 | 7 | 2 | 2015 |
1 organizations
Page 1 / 1